Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. (Q40876012)

24 September 2017

title

Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. (English)

1 reference

24 September 2017

Mittman N

1

1 reference

24 September 2017

Sreedhara R

2

1 reference

24 September 2017

Mushnick R

3

1 reference

24 September 2017

Chattopadhyay J

4

1 reference

24 September 2017

Zelmanovic D

5

1 reference

24 September 2017

Vaseghi M

6

1 reference

24 September 2017

Avram MM

7

1 reference

24 September 2017

publication date

1 December 1997

1 reference

American Journal of Kidney Diseases

24 September 2017

published in

1 reference

24 September 2017

volume

30

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

912-922

1 reference

Anemia of end-stage renal disease (ESRD).

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Haemolysis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

The bleeding disorder of uraemia. A qualitative platelet defect

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

The kidney and erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Iron balance in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Iron management in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Iron status in patients receiving erythropoietin for dialysis-associated anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

THE DIAGNOSIS OF IRON DEFICIENCY ANEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990104-9

7 January 2021

10.1016/S0272-6386(97)90104-9

Identifiers

DOI

1 reference

24 September 2017

1 reference